Concentrated portion of plan members responsible for 53% of total drug costs in 2019: report
Over the past four years, total drug costs adjudicated by HBM+ have risen from about $1.2 billion to $1.5 billion, while the number of claimants has increased from 1.7 million to more than two million. The inaugural drug trends and strategic insights report by the health benefits manager, a division of Green Shield Canada, examined drug […]
- September 18, 2020 November 17, 2020
- 15:00